Published in Ter Arkh on January 01, 1997
[Increase in NETO2 gene expression is a potential molecular genetic marker in renal and lung cancers]. Genetika (2012) 0.84
[Expression of FTL and FTH genes encoding ferretin subunits in lung and renal carcinomas]. Mol Biol (Mosk) (2010) 0.83
The monitoring of acute leukemia patients: Part 1. Basic morphometric characteristics of bone marrow blast cells in acute lymphoblastic leukemia. Leuk Res (1990) 0.82
[Stimulation of proliferation by carnosine: cellular and transcriptome approaches]. Mol Biol (Mosk) (2015) 0.78
[Genetic diversity and evolution of the influenza C virus]. Genetika (2012) 0.76
[Efferent connections of the centrum medianum of the cat thalamus demonstrated by the autoradiographic technic]. Neirofiziologiia (1984) 0.76
[Method of withdrawal of large quantities of autologous bone marrow from the vertebral bodies of dogs]. Probl Gematol Pereliv Krovi (1982) 0.75
[Surgical results with hematologic patients]. Vestn Khir Im I I Grek (1982) 0.75
[Colony-forming capacity of bone marrow cells in patients with hypoplastic anemia]. Gematol Transfuziol (1984) 0.75
[Transition of hypoplastic anemia into acute leukemia]. Probl Gematol Pereliv Krovi (1968) 0.75
[Hemopoiesis in hypoplastic and aplastic anemia according to the puncture material and sections of bone marrow trephination material]. Probl Gematol Pereliv Krovi (1967) 0.75
[Evaluation of fludarabine-containing regimens versus immunochemotherapy for chronic lymphocytic leukemia]. Ter Arkh (2010) 0.75
[Molecular characterization of pandemic influenza viruses A/H1N1(sw2009) isolated in Russia in 2009-2010]. Zh Mikrobiol Epidemiol Immunobiol (2011) 0.75
[Thrombocyte ultrastructural and functional characteristics in hypoplastic anemia patients]. Probl Gematol Pereliv Krovi (1981) 0.75
[A method of differentiated combined treatment of patients with hypoplastic anemia after splenectomy]. Gematol Transfuziol (1983) 0.75
[Preparation stimulating hair growth possibly acts by inhibiting hair follicle ageing experiments on mice and transcriptome analysis]. Adv Gerontol (2014) 0.75
[Effect of combined treatment on erythrocyte life span in hypoplastic anemia]. Probl Gematol Pereliv Krovi (1980) 0.75
[Determination of peroxidase activity in the ultrastructure of bone marrow cells in leukemia]. Lab Delo (1983) 0.75
[Myelocytic leukemia transformed into reticulosarcomatosis]. Ter Arkh (1976) 0.75
[Hypothalamic projections into the midbrain reticular formation and the parafascicular complex in the cat detected by means of retrograde horseradish peroxidase transport]. Arkh Anat Gistol Embriol (1980) 0.75
[Diagnostic value of the study of material of trephine biopsies in patients with hypo- and aplastic anemia]. Probl Gematol Pereliv Krovi (1975) 0.75
[Basic principles of blood transfusion therapy in splenectomy on hypoplastic anemia patients]. Probl Gematol Pereliv Krovi (1978) 0.75
[Metabolic and kinetic characteristics of blast cells in acute leukemias in the initial period and during relapse]. Gematol Transfuziol (1983) 0.75
[Complications of an ulcerative-necrotic lesion of the gastrointestinal tract in hemoblastosis patients]. Probl Gematol Pereliv Krovi (1981) 0.75
[Bacterial flora and certain indicators of nonspecific reactivity of the body in hypo-aplastic anemias]. Probl Gematol Pereliv Krovi (1973) 0.75
[Differentiated therapy of hypoplastic anemia patients in relation to the immunomorphological status of their bone marrow]. Gematol Transfuziol (1985) 0.75
[Cyclophosphane treatment of patients with partial red cell aplasia]. Gematol Transfuziol (1987) 0.75
[Status of nonspecific defense factors in patients with chronic myeloproliferative diseases]. Gematol Transfuziol (1990) 0.75
[Significance of polyamines for the early diagnosis of spontaneous hemoblastoses in AKR mice]. Vopr Onkol (1988) 0.75
[Tactics of the surgeon during performance of splenectomy in patients with hypo- and aplastic anemia]. Probl Gematol Pereliv Krovi (1968) 0.75
[Prevention and treatment of hemodynamic disorders in subacute hypoplastic anemia after splenectomy]. Probl Gematol Pereliv Krovi (1976) 0.75
[Clinico-immunologic aspects of idiopathic neutropenias]. Klin Med (Mosk) (1990) 0.75
[Determination of the activity of the pathologic process in hypoplastic (aplastic) anemia]. Gematol Transfuziol (1993) 0.75
[Stability of hematopoiesis and its laboratory indices (review of the literature)]. Lab Delo (1988) 0.75
[Pathogenesis of the development of fibroreticular tissue in patients with chronic myeloleukemia]. Gematol Transfuziol (1988) 0.75
[Electron microscopic characteristics of bone marrow lymphocytes in hypo- and aplastic anemias]. Probl Gematol Pereliv Krovi (1978) 0.75
[Ascending and descending efferent pathways of the midbrain reticular formation of the cat (radioautographic study)]. Arkh Anat Gistol Embriol (1985) 0.75
[Polymorphism of KPI-A genes from plants of the subgenus Potatoe (sect. Petota, Estolonifera and Lycopersicum) and subgenus Solanum]. Mol Biol (Mosk) (2013) 0.75
[Direct projections of the thalamic centrum medianum in the cerebral cortex of the cat (radioautographic studies)]. Arkh Anat Gistol Embriol (1983) 0.75
[Successful treatment of a patient having partial hypoplastic anemia with cyclophosphan]. Probl Gematol Pereliv Krovi (1976) 0.75
[Treatment principles and procedure in hypoplastic anemia]. Sov Med (1981) 0.75
[Immunosuppressive action of polyamines in patients with chronic myeloid leukemia]. Gematol Transfuziol (1994) 0.75
[The role of splenectomy in treating severe aplastic anemia]. Gematol Transfuziol (1996) 0.75
[Characteristics of the immunohematological indicators in patients with hypoplastic anemia during remission]. Gematol Transfuziol (1983) 0.75
[Phagocytosis and bactericidal properties of the blood serum in hypoplastic hemopoiesis]. Ter Arkh (1970) 0.75
[Criteria of differential diagnosis of chronic myeloproliferative diseases]. Gematol Transfuziol (1991) 0.75
[Vitamin B 12 and serum protein content of the blood in hypo- and aplastic anemias]. Probl Gematol Pereliv Krovi (1970) 0.75
[Valve of the radioisotope method of study in the determination of indications for splenectomy in patients with hypo- and aplastic anemia]. Probl Gematol Pereliv Krovi (1975) 0.75
[Levamisole in the treatment of hypoplastic anemia]. Gematol Transfuziol (1984) 0.75
[Methylation of DNA in Streptomyces coeruleorubidus cells]. Dokl Akad Nauk SSSR (1991) 0.75
[Splenectomy in the treatment of hypo- and aplastic anemia]. Sov Med (1970) 0.75
[Cytological characteristics of the formation of remission in acute leukemia]. Probl Gematol Pereliv Krovi (1981) 0.75
[Distribution in the cerebral cortex of neurons projecting into the median center of the thalamus and into the reticular formation of the midbrain]. Dokl Akad Nauk SSSR (1981) 0.75
[Pandemic influenza A/H1N1 (sw2009) in Russia: epidemiology, diagnosis, clinical picture, and treatment]. Ter Arkh (2010) 0.75
[New trends in the treatment of hypoplastic anemia]. Klin Med (Mosk) (1985) 0.75
[Value of cytological studies in acute leukemia]. Lab Delo (1981) 0.75
[Functional activity of neutrophils in patients with chronic myeloleukemia]. Gematol Transfuziol (1987) 0.75
[Acute myeloblastic leukemia]. Probl Gematol Pereliv Krovi (1980) 0.75
Study of hypothalamic projections to the mesencephalic reticular formation and parafascicular complex in cats by the retrograde HRP transport method. Neurosci Behav Physiol (1984) 0.75
[Prognostic value of cytochemical studies in chronic myeloleukemia]. Gematol Transfuziol (1984) 0.75
[Granulocyte ultrastructure in patients with hypoplastic anemia]. Gematol Transfuziol (1983) 0.75
[Hemostatic changes during the treatment of acute promyelocytic leukemia with all-transretinoic acid]. Ter Arkh (2000) 0.75
[Change in the immunoglobulins and nonspecific defense factors in hypoplastic anemia]. Probl Gematol Pereliv Krovi (1980) 0.75
[Biochemical and cytochemical criteria for predicting the course of acute lymphoblastic leukemia in children]. Gematol Transfuziol (1991) 0.75
[Bone marrow transplantation in the treatment of aplastic anemia patients]. Ter Arkh (1993) 0.75
[The prognostic significance of parameters of bone marrow blast cell proliferation in patients with acute leukemia]. Gematol Transfuziol (1989) 0.75
[Characteristics of immunological status of patients with lymphoblastic leukemia in relation to therapy]. Gematol Transfuziol (1985) 0.75
[Proliferative activity of leukemic cells taking into account the aggressive development of chronic myeloleukemia]. Gematol Transfuziol (1983) 0.75
[Indications for using androgens in hypoplastic anemia]. Gematol Transfuziol (1984) 0.75